Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction

The Journal of Clinical Psychiatry
A K Ashton, R C Rosen

Abstract

Serotonin reuptake inhibiting antidepressants (SRIs) are reported to cause sexual dysfunctions, including reduction in desire, arousal, and orgasm. This study evaluates the efficacy of bupropion in ameliorating sexual dysfunctions in patients receiving SRIs. Forty-seven patients in an outpatient psychiatric practice who complained of SRI-induced sexual dysfunction accepted a trial of bupropion as an adjunct to their SRI, either as a p.r.n. or as a fixed-dose scheduled medicine. Patients received 75 mg or 150 mg of bupropion 1 to 2 hours before sexual activity. If this was insufficient to reduce their complaints, dose was increased gradually to 75 mg t.i.d. and sustained for 2 weeks. This regimen was then continued if successful. Bupropion successfully reversed a variety of sexual dysfunctions caused by SRIs in 31 (66%) of 47 patients. Fifty-two (69%) of 75 sexual complaints improved with bupropion treatment. The p.r.n. use of bupropion assisted 18 (38%) of 47 patients. Side effects of anxiety and tremor led to discontinuation of bupropion in 7 (15%) of 47 patients. Otherwise, bupropion was well tolerated. Bupropion administration may be a safe and effective method of treating SRI-induced sexual dysfunction. Placebo-controlled, ...Continue Reading

Citations

May 17, 2001·Current Psychiatry Reports·S N Seidman, S P Roose
Jul 10, 2002·Journal of Affective Disorders·S A MontgomeryA Riley
Aug 11, 2001·Clinical Psychology Review·K Mah, Y M Binik
Nov 12, 2002·The Journal of Emergency Medicine·Martin G Belson, Todd R Kelley
Aug 10, 2000·Journal of Sex & Marital Therapy·J G ModellC R Katholi
Mar 16, 2002·Journal of Sex & Marital Therapy·Michael J GitlinLynn Fairbanks
Dec 17, 2004·Clinical Neuropharmacology·Renato P Munhoz
Aug 21, 2009·Obstetrical & Gynecological Survey·Joseph M Novi, Nicole M Book
Mar 5, 2011·Biological & Pharmaceutical Bulletin·Jillissa Christine MolnariAlan Lewis Myers
Jul 23, 1999·Pharmacotherapy·M A Gutierrez, G L Stimmel
Jul 17, 2007·Primary Care Companion to the Journal of Clinical Psychiatry·Jodie V Malhotra, Cynthia A Mascarenas
May 18, 2000·Clinical Therapeutics·A J Rothschild
Feb 5, 1999·Hospital Practice·B E Moore, A J Rothschild
Apr 1, 2015·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Juliane KopfAndreas Reif
Jan 29, 2011·The Journal of Sexual Medicine·Jennifer L Moll, Candace S Brown
Jan 21, 2006·The Journal of Sexual Medicine·Chris G McMahonZhong Cheng Xin
Nov 7, 2007·The Urologic Clinics of North America·Antoine MakhloufCraig S Niederberger
Aug 18, 2016·Sexual Medicine Reviews·Daniel J SadowskiTobias S Köhler
Sep 17, 2005·Biological Psychiatry·Sidney ZisookCarol B Rockett
Jul 15, 2004·Pharmacology, Biochemistry, and Behavior·Anders AgmoHelge Kaspersen
Jan 11, 2000·Emergency Medicine Clinics of North America·J Sarko
May 28, 2015·Andrology·M J ButcherT S Köhler
Apr 2, 2014·Postgraduate Medicine·Anita H ClaytonLata Handiwala
Aug 16, 2016·The Psychiatric Clinics of North America·Anita H ClaytonJennifer G Votta
Sep 24, 2002·The Annals of Pharmacotherapy·Razmic S GregorianZeba M Khan
Nov 24, 1998·The Annals of Pharmacotherapy·S T Woodrum, C S Brown
Sep 24, 1999·The Annals of Pharmacotherapy·J C YollesA O Alao
Nov 17, 2005·The Annals of Pharmacotherapy·Regina GinzburgJonathan S Fader
Oct 13, 2009·Journal of Psychiatric Practice·Jonathan W StewartFrederic M Quitkin
Mar 1, 2008·Journal of Psychopharmacology·K Demyttenaere, L Jaspers
Nov 1, 2002·International Clinical Psychopharmacology·J J WorthingtonUNKNOWN Anxiety Disorders Research Program
Apr 29, 2006·Journal of Psychopharmacology·Charles DeBattista
Nov 27, 2001·British Medical Bulletin·D S Baldwin
Feb 24, 2001·Journal of Clinical Psychopharmacology·L A LabbateG W Arana
Oct 12, 2010·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Joachim FrostOlav Spigset
Feb 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Akira KugayaRobert B Innis
Jan 25, 2003·Journal of Clinical Psychopharmacology·Charles DeBattistaAlan F Schatzberg
Feb 6, 1999·Journal of Clinical Psychopharmacology·R C RosenM Menza
Jan 9, 2016·Iranian Red Crescent Medical Journal·Alireza ZahiroddinNajmeh Shahini
Jun 28, 2002·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Robert Taylor Segraves
Jun 4, 2013·The Cochrane Database of Systematic Reviews·Matthew J TaylorKeith Hawton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.